CBNPC Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures (NCT06713798) | Gustave Roussy, Cancer Campus, Grand Paris | 2025-01-30 |
Track CBNPC Cancer automatically
Every clearance here is in the API, with alerts when new ones post.